Enhanced antitumor immunity of mRNA vaccines by bioorthogonal-like delayed activation of exogeneous STING
Nature Biotechnology, Published online: 19 August 2026; doi:10.1038/s41587-026-03224-y mRNA vaccine efficacy is enhanced by delayed activation of a STING adjuvant.
We haven't written up this one. Nature Biotechnology has the full story — the link below goes straight to it.